Skip to main content
Clinical Trials/NCT04442828
NCT04442828
Recruiting
Not Applicable

3D Echocardiography and Cardiovascular PRognosis In Mitral REgurgitation (3D-PRIME)

Haukeland University Hospital1 site in 1 country300 target enrollmentApril 17, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mitral Regurgitation
Sponsor
Haukeland University Hospital
Enrollment
300
Locations
1
Primary Endpoint
Major cardiovascular event
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The 3D-PRIME study will analyse whether use of 3D echocardiography can improve risk stratification and cardiovascular outcome in patients with mitral regurgitation of different etiologies.

Registry
clinicaltrials.gov
Start Date
April 17, 2020
End Date
April 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Haukeland University Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult patients with primary or secondary mitral regurgitation (MR)
  • MR of moderate or severe degree
  • 3D echocardiographic examinations of \>= good spatial and temporal resolution

Exclusion Criteria

  • Co-existence of another valve disease of severe degree
  • Inability to give informed consent

Outcomes

Primary Outcomes

Major cardiovascular event

Time Frame: 24 months

Death, mitral valve intervention, heart failure hospitalization

Secondary Outcomes

  • Cardiovascular death(24 months)
  • All-cause death(24 months)
  • Mitral valve intervention(24 months)

Study Sites (1)

Loading locations...

Similar Trials